Why the study?
Certain groups of patients with heart failure have limitations regarding conventional electrotherapy, creating interest in cardiac contractility modulation for those outside current guidelines.
This review summarizes the scientific evidence for cardiac contractility modulation as a treatment modality for heart failure patients who do not meet standard guidelines for electrotherapy.
Answers are grounded in this paper and cite their sources.
May extend electrotherapy to select HF patients outside guidelines; leaves open need for randomized confirmation before practice change.
Patients with heart failure (HF) are being benefi ted by electric therapy through conventional pacemakers when associated to bradycardia and cardiac resynchronization therapy or with low ejection fraction and presence of QRS longer than 150 ms, mainly in the presence of left branch block. Other groups of patients with HF present limitations regarding electrotherapy. However, an old concept has gained space in the treatment of patients who are outside the national and international guidelines for electrotherapy in HF: the modulation of heart contractility. This article has the purpose of presenting a review of already produced scientifi c evidence regarding this new modality for HF treatment
No takes yet. Share an insight, caveat, or question.
Silvestrini et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: